Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC)

Furthermore, we evaluated the clinical outcome of all 31 TNBC patients in a follow-up time ranging from 24 months to 36 months separating them in a free-survival group (23 women) and a recurrence group (8 women with local recurrence or distant metastasis): only kinetic curves resulted to be significantly higher in recurrence group (p = 0.042).